New York City, New York Jan 3, 2020 (Issuewire.com) - Dr. Arcila is a molecular genetic pathologist and a hematopathologist. As such, her work primarily involves the study and detection of genetic changes in cancer tissue. These changes can be used to diagnose and confirm the presence of individual cancer types and help tailor patient-specific treatment, determine patients’ prognosis and risk of recurrence, and monitor their disease once they start therapy. The doctor also works closely with clinical colleagues to diagnose diseases that affect the blood and lymphoid systems. She directly examines tissue and blood samples to diagnose, stage, and monitor hematologic cancers such as leukemia, lymphoma, myeloma, and other diseases at both the morphologic and molecular levels.
In her current role, Dr. Arcila serves as the Director of the Diagnostic Molecular Pathology Laboratory at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City, New York. Founded in 1884 as the New York Cancer Hospital, MSKCC is the largest and oldest private cancer treatment and research institution in the world and is one of 70 National Cancer Institute-designated Comprehensive Cancer Centers.
The doctor’s research is focused on the molecular changes that fuel the development of lung carcinoma and the search for possible therapeutic and prognostic markers in patients with this disease. Because of this interest, Dr. Arcila has become directly involved with the expansion, validation, and implementation of clinical tests at Memorial Sloan Kettering to detect mutations relevant to the management and treatment of patients with lung carcinoma.
Throughout her academic career, she earned her medical degree from the University of Pittsburgh School of Medicine. She then went on to complete her residencies at Tripler Army Medical Center and Madigan Army Medical Center, followed by her fellowship at Memorial Sloan Kettering Cancer Center.
Thereafter, she became board-certified in molecular genetic pathology, hematology, as well as anatomic and clinical pathology by the American Board of Pathology, one of the 24 member boards of the American Board of Medical Specialties.
In addition to being a local, national, and international speaker, Dr. Arcila has published well over 200 papers. She is a member of multiple professional organizations, including the College of American Pathologists, the American Society for Clinical Pathology, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.
Molecular genetic pathology is the subspecialty of medical genetics and pathology in which the principles, theory, and technologies of molecular biology and molecular genetics are used to make or confirm clinical diagnosis of mendelian genetic disorders, disorders of human development, infectious diseases, and malignancies; to assess the natural history of those disorders; and to provide the primary physician with information with which to provide optimal care for individuals affected with these disorders.
Hematopathology is the study of diseases and disorders affecting blood cells, their production, and any organs and tissues involved in hematopoiesis, such as bone marrow, the spleen, and the thymus. Hematopathologists are highly trained healthcare providers who specialize in diseases of the blood and blood components. These include blood and bone marrow cells. Hematological tests can help diagnose anemia, infection, hemophilia, blood-clotting disorders, and leukemia.
Learn more about Dr. Maria E. Arcila:
Through her findatopdoc profile, https://www.findatopdoc.com/doctor/3204581-Maria-Arcila-Pathologist or through Memorial Sloan Kettering Cancer Center, https://www.mskcc.org/cancer-care/doctors/maria-arcila
About FindaTopDoc.com
FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family.
Media Contact
Your Health Contact *****@yourhealthcontact.com
